GMDS Antikörper (N-Term)
Kurzübersicht für GMDS Antikörper (N-Term) (ABIN5517890)
Target
Alle GMDS Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- N-Term
-
Sequenz
- HAPARCPSAR GSGDGEMGKP RNVALITGIT GQDGSYLAEF LLEKGYEVHG
-
Aufreinigung
- Affinity purified
-
Immunogen
- The immunogen is a synthetic peptide directed towards the N terminal region of human GMDS
-
-
-
-
Applikationshinweise
- Optimal working dilution should be determined by the investigator.
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Buffer
- Liquid. Purified antibody supplied in 1x PBS buffer with 0.09 % (w/v) sodium azide and 2 % sucrose.
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Lagerung
- -20 °C
-
Informationen zur Lagerung
- For short term use, store at 2-8°C up to 1 week. For long term storage, store at -20°C in small aliquots to prevent freeze-thaw cycles.
-
-
- GMDS (GDP-Mannose 4,6-Dehydratase (GMDS))
-
Andere Bezeichnung
- GMDS
-
Hintergrund
-
GDP-mannose 4,6-dehydratas catalyzes the conversion of GDP-mannose to GDP-4-keto-6-deoxymannose, the first step in the synthesis of GDP-fucose from GDP-mannose, using NADP+ as a cofactor. The second and third steps of the pathway are catalyzed by a single enzyme, GDP-keto-6-deoxymannose 3,5-epimerase, 4-reductase, designated FX in humans.
Alias Symbols: GMD, SDR3E1
Protein Size: 372 -
Gen-ID
- 2762
-
NCBI Accession
- NM_001253846, NP_001240775
-
UniProt
- O60547
Target
-